Müller S - Search Results

1

Prognostic and predictive value of tumor vascular endothelial growth factor gene amplification in metastatic breast cancer treated with paclitaxel with and without bevacizumab; results from ECOG 2100 trial.

Schneider BP, Gray RJ, Radovich M, Shen F, Vance G, Li L, Jiang G, Miller KD, Gralow JR, Dickler MN, Cobleigh MA, Perez EA, Shenkier TN, Vang Nielsen K, Müller S, Thor A, Sledge GW Jr, Sparano JA, Davidson NE, Badve SS. Schneider BP, et al. Among authors: muller s. Clin Cancer Res. 2013 Mar 1;19(5):1281-9. doi: 10.1158/1078-0432.CCR-12-3029. Epub 2013 Jan 22. Clin Cancer Res. 2013. PMID: 23340303 Free PMC article. Clinical Trial.

2

Amplified in breast cancer 1 in human epidermal growth factor receptor - positive tumors of tamoxifen-treated breast cancer patients.

Kirkegaard T, McGlynn LM, Campbell FM, Müller S, Tovey SM, Dunne B, Nielsen KV, Cooke TG, Bartlett JM. Kirkegaard T, et al. Among authors: muller s. Clin Cancer Res. 2007 Mar 1;13(5):1405-11. doi: 10.1158/1078-0432.CCR-06-1933. Clin Cancer Res. 2007. PMID: 17332282

3

Amplification of ESR1 may predict resistance to adjuvant tamoxifen in postmenopausal patients with hormone receptor positive breast cancer.

Nielsen KV, Ejlertsen B, Müller S, Møller S, Rasmussen BB, Balslev E, Lænkholm AV, Christiansen P, Mouridsen HT. Nielsen KV, et al. Among authors: muller s. Breast Cancer Res Treat. 2011 Jun;127(2):345-55. doi: 10.1007/s10549-010-0984-y. Epub 2010 Jun 17. Breast Cancer Res Treat. 2011. PMID: 20556506

4

Prognostic and predictive role of ESR1 status for postmenopausal patients with endocrine-responsive early breast cancer in the Danish cohort of the BIG 1-98 trial.

Ejlertsen B, Aldridge J, Nielsen KV, Regan MM, Henriksen KL, Lykkesfeldt AE, Müller S, Gelber RD, Price KN, Rasmussen BB, Viale G, Mouridsen H; Danish Breast Cancer Cooperative Group the BIG 1-98 Collaborative Group and the International Breast Cancer Study Group. Ejlertsen B, et al. Among authors: muller s. Ann Oncol. 2012 May;23(5):1138-1144. doi: 10.1093/annonc/mdr438. Epub 2011 Oct 10. Ann Oncol. 2012. PMID: 21986093 Free PMC article.

5

Frequent amplifications and deletions of G1/S-phase transition genes, CCND1 and MYC in early breast cancers: a potential role in G1/S escape.

Jensen LB, Bartlett JM, Witton CJ, Kirkegaard T, Brown S, Müller S, Campbell F, Cooke TG, Nielsen KV. Jensen LB, et al. Among authors: muller s. Cancer Biomark. 2009;5(1):41-9. doi: 10.3233/CBM-2009-0570. Cancer Biomark. 2009. PMID: 19242061

6

Topoisomerase 1(TOP1) gene copy number in stage III colorectal cancer patients and its relation to prognosis.

Rømer MU, Nygård SB, Christensen IJ, Nielsen SL, Nielsen KV, Müller S, Smith DH, Vainer B, Nielsen HJ, Brünner N. Rømer MU, et al. Among authors: muller s. Mol Oncol. 2013 Feb;7(1):101-11. doi: 10.1016/j.molonc.2012.09.001. Epub 2012 Oct 11. Mol Oncol. 2013. PMID: 23110915 Free PMC article.

7

Genetic alterations of CCND1 and EMSY in breast cancers.

Kirkegaard T, Nielsen KV, Jensen LB, Campbell FM, Müller S, Tovey SM, Brown S, Cooke TG, Bartlett JM. Kirkegaard T, et al. Among authors: muller s. Histopathology. 2008 May;52(6):698-705. doi: 10.1111/j.1365-2559.2008.03007.x. Epub 2008 Apr 2. Histopathology. 2008. PMID: 18393977

8

Lack of independent prognostic and predictive value of centromere 17 copy number changes in breast cancer patients with known HER2 and TOP2A status.

Nielsen KV, Ejlertsen B, Møller S, Jensen MB, Balslev E, Müller S, Knoop A, Mouridsen HT. Nielsen KV, et al. Among authors: muller s. Mol Oncol. 2012 Feb;6(1):88-97. doi: 10.1016/j.molonc.2011.11.006. Epub 2011 Nov 26. Mol Oncol. 2012. PMID: 22153616 Free PMC article.

9

Mechanisms of topoisomerase I (TOP1) gene copy number increase in a stage III colorectal cancer patient cohort.

Smith DH, Christensen IJ, Jensen NF, Markussen B, Rømer MU, Nygård SB, Müller S, Nielsen HJ, Brünner N, Nielsen KV. Smith DH, et al. Among authors: muller s. PLoS One. 2013;8(4):e60613. doi: 10.1371/journal.pone.0060613. Epub 2013 Apr 5. PLoS One. 2013. PMID: 23577133 Free PMC article.

10

ESR1 gene status correlates with estrogen receptor protein levels measured by ligand binding assay and immunohistochemistry.

Laenkholm AV, Knoop A, Ejlertsen B, Rudbeck T, Jensen MB, Müller S, Lykkesfeldt AE, Rasmussen BB, Nielsen KV. Laenkholm AV, et al. Among authors: muller s. Mol Oncol. 2012 Aug;6(4):428-36. doi: 10.1016/j.molonc.2012.04.003. Epub 2012 May 8. Mol Oncol. 2012. PMID: 22626971 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

5,532 results

Search Page